Molybdenum-99 Market by Isotopic Application, End User & Region | Forecast 2023 to 2033
Molybdenum-99 Use in Radiotherapy and Better Healthcare Possibilities Enhance Global Development- Explore Latest Trends from FMI in More Than 30 Countries
According to FMI projection, the molybdenum-99 market could reach a value of US$ 7.28 billion. With a forecast market size of US$ 4.48 billion in 2023, it continues to be one of the radioisotopes that are most frequently utilized in nuclear diagnostic medical operations.
In response to the need for molybdenum-99 to visualize the structure and function of a tissue, organ, bone, or system within the body, a CAGR of 5.0% is projected by 2033. The global Y-o-Y growth for the molybdenum-99 is currently estimated at a little below 5%. However, recently procuring 99Mo has become increasingly difficult.
Various factors are responsible for this, including the shutting down of some nuclear reactors and uncertainties pertaining to reliable operating conditions. Nonetheless, increasing investment in production infrastructure and recent approvals of 99Mo and products derived from it offers substantial economic incentives to the market players.
Innovations are on the cards. However, any new processes with possibilities of influencing product quality in comparison to the existing counterparts must be licensed and demonstrated to realize their market potential.
Attributes
Details
Molybdenum-99 Market CAGR (2023 to 2033)
5.0%
Molybdenum-99 Market Size (2023)
US$ 4.48 billion
Molybdenum-99 Market Size (2033)
US$ 7.28 billion
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Rising Use of Radiotherapy: A Ground-breaking Strategy
The rising penetration of radio-therapeutics is expected to be the chief driver of the global market. Radiotherapeutics is already touted as the next wave in medicine, accounting for nearly 13% of the nuclear medicine market.
As a result of the increasing incidence of prostate and bone cancers, the demand for effective treatment and innovation in medicine is at an all-time high. This is also the primary reason driving investment in radio therapeutics, which has augured well for the molybdenum-99 sector.
Studies suggest that prostate cancer is the second-leading cause of cancer-related deaths in the United States. Despite a significant reduction in fatality in the last couple of years, the disease has continued to cost precious human lives despite advancements in screening methods and treatment.
Penetration of radio-therapeutics is therefore considered a path-breaking move in the cancer diagnostic market. The launch of molybdenum-99 for the treatment of bone and prostate cancer is therefore considered an indispensable move in the medical world.
In the coming years, greater discoveries are on the card, especially as leading players continue investing in advancements. For instance, the demand for effective treatment of tumors impelled the launch of novel radiotherapeutics by GE Healthcare.
How Does the Future Forecast Compare to Past Sales of Molybdenum-99?
Molybdenum-99 usage in nuclear power plants is predicted to increase, along with expanding interest in nuclear energy, and the CAGR remains steady, which is 5% for both time periods. In 2022, the market had a valuation of US$ 4.25 billion.
This is primarily attributed to the need for capacity expansion. While the current supply of 99Mo is considered sufficient to meet global demand, changing the supply chain might result in severe shortages. This can adversely impact the delivery of medical care.
Technetium-99m obtained from 99Mo is one of the primary isotopes used in radionuclide medical imaging. It helps in noninvasively evaluating regional metabolic and psychological processes, such as cardiac blood flow, to localize the affected tissue or organ.
During the forecast period, the market is anticipated to be driven by increased demand for molybdenum-99 generators from nations in the Asia Pacific region and an increase in the number of nuclear medicine facilities. As a result, the molybdenum 99 generator market is also expanding significantly. Despite this, a number of initiatives lead the market to make an absolute dollar opportunity of US$ 253 million during the forecast period. Such initiatives are:
Creating new techniques for nuclear reactors to produce molybdenum-99.
The expansion of molybdenum-99's accessibility and cost for use in medical imaging.
Creating radiopharmaceuticals based on molybdenum-99 for medical imaging.
Developing molybdenum-99-based radiopharmaceuticals for cancer treatment.
Developing technologies for recycling and reusing molybdenum-99
Developing new methods for safely disposing of molybdenum-99.
Investigating the environmental impacts of molybdenum-99 production.
Find your sweet spots for generating winning opportunities in this market.
Market Dynamics
Use of Molybdenum-99 in Managing Non-communicable Diseases
The demand for molybdenum-99 is rising in response to the increasing incidence of various non-communicable diseases, such as cancer and cardiovascular ailments.
As opposed to communicable diseases witnessed in underdeveloped countries, communicable diseases are primarily byproducts of an aging population, unhealthy and stressful life, and increasing life expectancy. Treatment of non-communicable diseases is often time-consuming and very complicated. A delay in diagnosis can further complicate a patient’s condition.
As a result of these factors, radio-therapeutics are increasingly adopted. Investment, too, is on the cards, especially since healthcare institutions are looking at offering improved patient care through precise diagnosis and accurate treatment.
Social and economic transformation in high-potential pockets has been creating a strong foundation for healthcare developments to happen. Improvement in living standards and per-capita income has made people more willing to spend on advanced treatment, creating a conducive environment for the growth of the 99Mo market.
Demand for molybdenum supplements has increased as a result of increased consumer health consciousness and growing awareness of healthy living. Molybdenum supplements market share in the molybdenum-99 market is projected to be between 10% and 15%.
What Impedes the Molybdenum-99 Industry?
The availability of technetium-99m or 99mTc is dependent on the production and supply of 99Mo from a limited number of nuclear reactors located around the world. Leading ones are close to shutting down, which has been leading to production disruption.
The looming closure of aged reactors or extended shutdowns for planned and unplanned maintenance works have been disrupting the market’s supply chain for the last couple of years.
With this, the demand for alternative imaging modalities has gained momentum, creating significant bottlenecks for the market. As a result of the anticipated shortage in the near future, healthcare institutions are shifting to PET, SPECT, and other imaging modalities, denting future prospects for the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Comparative View of Molybdenum-99 Market
Molybdenum-99 Market:
Attributes
Molybdenum-99 Market
CAGR (2023 to 2033)
5.0%
Market Value (2033)
US$ 7.28 billion
Growth Factor
Rising penetration of radiotherapy
Opportunity
Mo-99 technology aims at automation
Key Trends
Higher investment in the healthcare industry
Molybdenum Market:
Attributes
Molybdenum Market
CAGR (2023 to 2033)
4.7%
Market Value (2033)
US$ 500 billion
Growth Factor
Applications in multiple industries like aerospace, medical, energy, and others
Opportunity
Expanding need for its alloy in electronics
Key Trends
High focus on recycling processes
Molybdenum Disilicide Market:
Attributes
Molybdenum Disilicide Market
CAGR (2023 to 2033)
7.2%
Market Value (2033)
US$ 9.11 billion
Growth Factor
Surging utilization in production of ceramics, electronics.
Opportunity
Increasing use of innovative steel components
Key Trends
Existence of a cement production industry that is well-established in different regions
Regional Analysis
A large share of the global supply of molybdenum-99 is derived from irradiating targets, which is a solid plates containing aluminum-clad uranium found across seven reactors located in Canada, Australia, Europe, and South Africa.
Country
United States
Market CAGR (2017 to 2022)
4.9%
Absolute Dollar Growth
US$ 106.5 million
Country
China
Market CAGR (2017 to 2022)
6.9%
Absolute Dollar Growth
US$ 10.6 million
Country
Canada
Market CAGR (2017 to 2022)
5.8%
Absolute Dollar Growth
US$ 13.8 million
Country
Germany
Market CAGR (2017 to 2022)
5.0%
Absolute Dollar Growth
US$ 9.2 million
Country
United Kingdom
Market CAGR (2017 to 2022)
4.9%
Absolute Dollar Growth
US$ 8 million
United States Overcoming the Supply Shortage of Molybdenum-99
Future Market Insights (FMI) finds that the capacity of supply has been significantly affected since Canada stopped production towards the end of October 2016. Current efforts are therefore dedicated to increasing the supply by expanding existing production overseas.
As the United States is likely to face serious shortages due to limited supply from Canada, efforts are now being dedicated to the expansion of production in overseas locations.
There is also considerable focus on initiating domestic production by methods not requiring highly enriched uranium. Various leading institutions are determining strategic moves to fill the gap in the existing supply chain. Further delays in additional supplies of 99Mo can expose the market to the risk of substantial shortage.
This issue is solved by the presence of a sophisticated healthcare network, constituting hospitals and diagnostic centers with state-of-the-art infrastructure that has been of support as well. The United States is likely to dominate the market with a 4.3% CAGR and a valuation of US$ 3,103.4 million by 2033.
The region's growth is backed by high demand in the United States, coupled with the country’s favorable healthcare reimbursement policies.
Governments in North America often extend support via managed care plans and comprehensive healthcare support. Spurred by this, the demand for 99Mo is considerably high in North America. Canada is likely to account for a 6.4% CAGR and a valuation of US$ 355 million by 2033.
Europe Improved Healthcare Facilities Creates a Favorable Molybdenum-99 Market Outlook
Europe, too has emerged as a lucrative market for molybdenum-99. Between 2023 and 2033, the Europe market is forecast to exhibit steady growth. The rising demand from countries such as Germany, the United Kingdom, France, and Spain has been crucial in enabling growth in the Europe market.
United Kingdom Market Outlook
Besides favorable reimbursement policies, a focus on innovations to offer better healthcare facilities is driving growth in the United Kingdom. The market is aided by the presence of sophisticated healthcare infrastructure. The market is likely to be worth US$ 245.5 million and has a CAGR of 3.8% by 2033 as a result of steadily expanding demand from hospitals and diagnostic centers.
Germany Market Outlook
By 2033, Germany is likely to provide the most to Europe's total value-$407 million. The demand in the nation is extremely strong, and the trend is not expected to change in the upcoming years. Also, the presence of several top businesses supports the growth being experienced in the area.
Advanced Healthcare Technologies: Boon to Asia Pacific Molybdenum-99 Demand
China’s rising investment in healthcare development and strengthening research and development initiatives bode well for the market. Penetration of advanced healthcare technologies is rising, which works in favour of growth in the region. However, a lack of trained professionals and poor healthcare facilities have been creating bottlenecks to growth in certain under-developed pockets.
The use of private healthcare is increasing in countries such as India. In fact, studies report remarkable growth in this sector since 2000. Additionally, insurance support extended by various government and non-government providers has been supporting patients and their families, encouraging them to spend on advanced healthcare.
In South Asia, too, hospitals have emerged as a more attractive segment than diagnostic centers. Demand from countries such as India, Thailand, Indonesia, and Malaysia supports the expansion of the market in the region.
Category Analysis
Segment
Isotopic Application
Top Segment
Gamma Camera
Market CAGR (2017 to 2022)
4.1%
Market CAGR (2023 to 2033)
3.1%
Segment
End Users
Top Segment
Hospitals
Market CAGR (2017 to 2022)
5.3%
Market CAGR (2023 to 2033)
4.9%
Based on Isotopic Application: Due to the growing usage of gamma cameras for medical imaging, such as for the diagnosis of cancer, cardiovascular diseases, and neurological disorders, this segment is anticipated to take the lead by 2033.
Based on End User: hospitals account for the leading share in the global market. Hospitals remain dominant, especially due to the rising healthcare spending recorded across the world.
It is also true that clinical and technological advances contribute to demand witnessed from hospitals and diagnostic centers alike.
New government administrations are pushing for affordable healthcare. This move has been of incredible importance for the market players.
The focus on making cancer treatment more affordable is expected to fuel demand from both end-use segments in the forthcoming years.
Competitive Analysis
Key Players in the Molybdenum-99 Industry Seek to Achieve High Investing Capacities
The need for technologies to create Mo-99 in an efficient and secure manner is increasing, along with the demand for the substance. To address this demand, businesses in the Mo-99 production technology market are creating cutting-edge methods and procedures. To lower production costs and boost safety, businesses are also creating new technologies and procedures.
The molybdenum market continues to be consolidated. Tier 1 players make up the bulk of the share. These businesses are at the forefront of numerous clinical studies that have been published in the market since they have higher investing capacities.
Mid-level players, too, are witnessing scope for expansion. In the coming years, the market is likely to see an immense focus on strengthening portfolios among the companies. Besides this, many of them also focus on the expansion of their footprint worldwide.
The key intent behind their strategies is to gain a competitive advantage. It is, therefore, a little surprising to witness investment towards research and development activities. Also, strategic collaborations are likely to become more common in the near future.
GE Healthcare signed an agreement with HealthTrust to supply radiopharmaceuticals in March 2017. It is, therefore, evidence that the company is focusing on boosting its supply via partnership agreements.
Curium Pharmaceuticals meanwhile acquired MAP Medical Technologies Oy, which is a radiopharmaceuticals company, in December 2019. The company intends to expand its footprint via this acquisition.
Key players
IBA
Sumitomo Corporation
Advanced Cyclotron Systems, Inc.
Siemens Healthineers
Key Segments
By Isotopic Application:
SPECT
Gamma Camera
By End User:
Hospitals
Diagnostic Centers
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Frequently Asked Questions
How Big is the Molybdenum-99 Market?
The Molybdenum-99 Market value reaches US$ 4.48 billion in 2023.
What are the Projected Dimensions of the Molybdenum-99 Market by 2033?
The Molybdenum-99 Market is anticipated to surpass US$ 7.28 billion by 2033, recording a CAGR of 5%.
Which is the Top Trend in the Molybdenum-99 Market?
The demand for molybdenum-99-based medical imaging methods is the main trend in the molybdenum-99 market.
Which Region Holds High Lucrativeness for Airbag Control Unit Sensors?
The Molybdenum-99 Market discovers profitable prospects within Asia Pacific.
Who is the Key Molybdenum-99 Market Players?
Key Molybdenum-99 Market players are Mallinckrodt, Nordian, IsoRay.
Table of Content
1. Executive Summary | Molybdenum-99 Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Production by Highly Enriched Uranium
5.3.2. Production by Non-Highly Enriched Uranium
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Medical
6.3.2. Scientific Research
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. The USA
8.2.1.2. Canada
8.2.2. By Type
8.2.3. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Type
8.3.3. By Application
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Type
9.2.3. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Application
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Type
10.2.3. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Application
10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Type
11.2.3. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Application
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Type
12.2.3. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Application
12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Type
13.2.3. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Application
13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Type
14.2.3. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Application
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Type
15.1.2.2. By Application
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Type
15.2.2.2. By Application
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Type
15.3.2.2. By Application
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Type
15.4.2.2. By Application
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Type
15.5.2.2. By Application
15.6. United Kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Type
15.6.2.2. By Application
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Type
15.7.2.2. By Application
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Type
15.8.2.2. By Application
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Type
15.9.2.2. By Application
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Type
15.10.2.2. By Application
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Type
15.11.2.2. By Application
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Type
15.12.2.2. By Application
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Type
15.13.2.2. By Application
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Type
15.14.2.2. By Application
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Type
15.15.2.2. By Application
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Type
15.16.2.2. By Application
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Type
15.17.2.2. By Application
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Type
15.18.2.2. By Application
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Type
15.19.2.2. By Application
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Type
15.20.2.2. By Application
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Type
15.21.2.2. By Application
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Type
16.3.3. By Application
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Curium Company
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Eckert & Ziegler Holding Company
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Shine Medical Technologies
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. NTP Radioisotopes SOC Ltd.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. North Star Medical Radioisotopes LLC
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. JSC Isotope
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. ANSTO
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Lantheus Medical Imaging Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. IRE ELIT
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Niowave Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Europe Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 12: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 13: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: South Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 15: South Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 16: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: East Asia Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 18: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: Oceania Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 21: Oceania Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 22: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 23: MEA Market Value (US$ Million) Forecast by Type, 2018 to 2033
Table 24: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 13: Global Market Attractiveness by Type, 2023 to 2033
Figure 14: Global Market Attractiveness by Application, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Type, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by Application, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 28: North America Market Attractiveness by Type, 2023 to 2033
Figure 29: North America Market Attractiveness by Application, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Type, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by Application, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Type, 2023 to 2033
Figure 44: Latin America Market Attractiveness by Application, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Europe Market Value (US$ Million) by Type, 2023 to 2033
Figure 47: Europe Market Value (US$ Million) by Application, 2023 to 2033
Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Europe Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 55: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 58: Europe Market Attractiveness by Type, 2023 to 2033
Figure 59: Europe Market Attractiveness by Application, 2023 to 2033
Figure 60: Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: South Asia Market Value (US$ Million) by Type, 2023 to 2033
Figure 62: South Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 63: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: South Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 68: South Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 70: South Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 71: South Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 72: South Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 73: South Asia Market Attractiveness by Type, 2023 to 2033
Figure 74: South Asia Market Attractiveness by Application, 2023 to 2033
Figure 75: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 76: East Asia Market Value (US$ Million) by Type, 2023 to 2033
Figure 77: East Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 78: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: East Asia Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 83: East Asia Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 85: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 86: East Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 88: East Asia Market Attractiveness by Type, 2023 to 2033
Figure 89: East Asia Market Attractiveness by Application, 2023 to 2033
Figure 90: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 91: Oceania Market Value (US$ Million) by Type, 2023 to 2033
Figure 92: Oceania Market Value (US$ Million) by Application, 2023 to 2033
Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 97: Oceania Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 98: Oceania Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 100: Oceania Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 101: Oceania Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 102: Oceania Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 103: Oceania Market Attractiveness by Type, 2023 to 2033
Figure 104: Oceania Market Attractiveness by Application, 2023 to 2033
Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 106: MEA Market Value (US$ Million) by Type, 2023 to 2033
Figure 107: MEA Market Value (US$ Million) by Application, 2023 to 2033
Figure 108: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 112: MEA Market Value (US$ Million) Analysis by Type, 2018 to 2033
Figure 113: MEA Market Value Share (%) and BPS Analysis by Type, 2023 to 2033
Figure 114: MEA Market Y-o-Y Growth (%) Projections by Type, 2023 to 2033
Figure 115: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 116: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 117: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 118: MEA Market Attractiveness by Type, 2023 to 2033
Figure 119: MEA Market Attractiveness by Application, 2023 to 2033
Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
